Skip to main content
Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.
- Author(s): Neumiller, Joshua J;
- Rhee, Connie M;
- Kalantar-Zadeh, Kamyar
- et al.
Published Web Locationhttps://doi.org/10.1159/000484669
For improved accessibility of PDF content, download the file to your device.